Mallory Doyle
Adult Health · Elizabethtown, KYNPI 1033718465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $721 and has fallen 84.7% since, to $110 in 2025.
Across 69 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$225
- Vifor Pharma, Inc.$172
- Fresenius USA Marketing, Inc.$147
- Akebia Therapeutics Inc$124
- Amgen$112
- Otsuka America Pharmaceutical, Inc.$83
- plus $385 from 13 others
What the payments were for
- Food & beverage$1,22898%
- Education$202%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 13 | $225 |
| Vifor Pharma, Inc. | 11 | $172 |
| Fresenius USA Marketing, Inc. | 8 | $147 |
| Akebia Therapeutics Inc | 7 | $124 |
| Amgen | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Mallinckrodt Hospital Products Inc. | 3 | $62 |
| Gilead | 2 | $51 |
| Ultragenyx Pharmaceutical Inc. | 3 | $45 |
| AbbVie | 1 | $35 |
| Exact Sciences | 1 | $27 |
| Pharmacosmos Therapeutics Inc. | 2 | $25 |
| Urogen Pharma, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Pfizer | 1 | $15 |
How this compares
$1,248 in reported general payments places this provider in the 65th percentile of 170 adult health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $25,005 |
| MounjaroTirzepatide | 18 | $24,666 |
| JanuviaSitagliptin Phosphate | 23 | $21,313 |
| JardianceEmpagliflozin | 12 | $9,620 |
| MyrbetriqMirabegron | 17 | $8,829 |
| Galantamine ErGalantamine Hbr | 22 | $2,887 |
| Estradiol (Once Weekly)Estradiol | 12 | $906 |
| Chlorthalidone | 36 | $801 |
| Pantoprazole Sodium | 40 | $705 |
| Atorvastatin Calcium | 72 | $675 |
| Rosuvastatin Calcium | 64 | $650 |
| Montelukast Sodium | 44 | $627 |
| Amlodipine Besylate | 105 | $555 |
| Metoprolol Succinate | 37 | $521 |
| Levothyroxine Sodium | 35 | $460 |
Paid to pharmacies, not to this prescriber.
Other adult health in Elizabethtown
- Joyce JohnsonElizabethtown$12K
- Carrie Clifford-BennettGeorgetown$730K
- Stephanie FlaspoehlerLouisville$174K
- Kimberly VesselsBrandenburg$58K
- Heidi GalloLouisville$15K
- Amy BakerPaducah$14K
- Karen EastridgeLouisville$10K
- Seon Hui BalistrereHopkinsville$8K
- Barbara CarpenterLouisville$8K
- Jennifer ThomasPaducah$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.